Maravai Lifesciences Holdings (MRVI) Inventory Average (2021 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly Inventory Average of $40.5 million for Q1 2026, down 18.93% year-over-year from $49.9 million in Q1 2025, and down 5.67% quarter-over-quarter from $42.9 million in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Inventory Average (2021 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Inventory Average history runs 6 years deep, the most recent figure standing at $40.5 million for Q1 2026.
- In Q1 2026, Inventory Average fell 18.93% year-over-year to $40.5 million; the TTM figure through Mar 2026 stood at $40.5 million (down 18.93% YoY), while the FY2025 annual figure was $45.3 million, down 10.74% from the prior year.
- Inventory Average for Q1 2026 stood at $40.5 million, down from $42.9 million in the prior quarter.
- The five-year high for Inventory Average was $61.3 million in Q3 2022, with the low at $40.5 million in Q1 2026.
- The 5-year median for Inventory Average is $49.9 million (2024), against an average of $49.9 million.
- The sharpest annual moves came in 2022 and 2023: Inventory Average rose 28.02% in 2022, then dropped 21.21% in 2023.
- Maravai Lifesciences Holdings' Inventory Average stood at $52.8 million in 2022, then retreated by 4.77% to $50.3 million in 2023, then increased by 0.08% to $50.3 million in 2024, then slipped by 14.7% to $42.9 million in 2025, then slipped by 5.67% to $40.5 million in 2026.
- Business Quant data shows MRVI's Inventory Average at $40.5 million in Q1 2026, $42.9 million in Q4 2025, and $46.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Maravai Lifesciences Holdings | 1.48 Bn | 1.56 Bn | 20.65 Mn | 40.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.85 Mn |
| Mar 31, 2026 | 40.48 Mn |
| Dec 31, 2025 | 42.91 Mn |
| Sep 30, 2025 | 46.00 Mn |
| Jun 30, 2025 | 48.22 Mn |
| Mar 31, 2025 | 49.93 Mn |
| Dec 31, 2024 | 50.31 Mn |
| Sep 30, 2024 | 49.94 Mn |
| Jun 30, 2024 | 49.59 Mn |
| Mar 31, 2024 | 50.62 Mn |
| Dec 31, 2023 | 50.27 Mn |
| Sep 30, 2023 | 48.27 Mn |
| Jun 30, 2023 | 51.11 Mn |
| Mar 31, 2023 | 48.99 Mn |
| Dec 31, 2022 | 52.79 Mn |
| Sep 30, 2022 | 61.27 Mn |
| Jun 30, 2022 | 55.76 Mn |
| Mar 31, 2022 | 51.48 Mn |
| Dec 31, 2021 | 53.90 Mn |
| Sep 30, 2021 | 52.01 Mn |